J&J Medical Connect
SPRAVATO®

(esketamine)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can I Take SPRAVATO If I Am Breastfeeding, Planning to Breastfeed, Pregnant, or Planning to Become Pregnant?

Last Updated: 01/24/2025

summary

Here is a passage from the SPRAVATO MEDICATION GUIDE which may be helpful to address your question:

Before you take SPRAVATO, tell your healthcare provider about all of your medical conditions, including if you1:

  • are breastfeeding or plan to breastfeed. SPRAVATO passes into your breastmilk. You should not breastfeed during treatment with SPRAVATO.
  • are pregnant or plan to become pregnant. SPRAVATO may harm your unborn baby. You should not take SPRAVATO if you are pregnant.
    • Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO.
    • If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO.
    • There is a pregnancy registry for women who are exposed to SPRAVATO during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO and their baby. If you become pregnant during treatment with SPRAVATO, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinicalandresearchprograms/pregnancyregistry/antidepressants/.

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest use in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the MEDICATION GUIDE for SPRAVATO.1

 

References

1 SPRAVATO (esketamine) nasal spray [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf